New research finds four out of five cancer therapies tested in Phase III trials do not achieve clinically-meaningful benefit in prolonging survival, and is the first study to quantify the number of false-positive, false-negative, and true-negative trial results.
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/09/210923102034.htm
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/09/210923102034.htm
Are too many Phase III cancer clinical trials set up to fail?
![Are too many Phase III cancer clinical trials set up to fail?]()
Reviewed by cmakigo
on
September 23, 2021
Rating:
No comments:
Post a Comment